Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.
Sozzi G, Boeri M, Rossi M, Verri C, Suatoni P, Bravi F, Roz L, Conte D, Grassi M, Sverzellati N, Marchiano A, Negri E, La Vecchia C, Pastorino U. Sozzi G, et al. Among authors: grassi m. J Clin Oncol. 2014 Mar 10;32(8):768-73. doi: 10.1200/JCO.2013.50.4357. Epub 2014 Jan 13. J Clin Oncol. 2014. PMID: 24419137 Free PMC article.
Prognosis of breast cancer in males: an analysis of 170 cases.
Salvadori B, Saccozzi R, Manzari A, Andreola S, Conti RA, Cusumano F, Grassi M. Salvadori B, et al. Among authors: grassi m. Eur J Cancer. 1994;30A(7):930-5. doi: 10.1016/0959-8049(94)90117-1. Eur J Cancer. 1994. PMID: 7946586
Surgical treatment of phyllodes tumors of the breast.
Salvadori B, Cusumano F, Del Bo R, Delledonne V, Grassi M, Rovini D, Saccozzi R, Andreola S, Clemente C. Salvadori B, et al. Among authors: grassi m. Cancer. 1989 Jun 15;63(12):2532-6. doi: 10.1002/1097-0142(19890615)63:12<2532::aid-cncr2820631229>3.0.co;2-q. Cancer. 1989. PMID: 2541890
Single-agent epirubicin as primary chemotherapy in T2-T3, N0-N2, M0 breast carcinoma: 6-year follow-up.
Barni S, Piazza E, Frontini L, Visini M, Ardizzoia A, Grassi MM, Nosenzo MA, Mandalà M, Biasioli R, Freddi E, Lucani L, Recalcati A, Pravettoni A, Sala R, Rezzani C, Villa S, Trabucchi E; Neo-Adjuvant Breast Italian Group. Barni S, et al. Among authors: grassi mm. Oncology. 2004;67(1):40-7. doi: 10.1159/000080284. Oncology. 2004. PMID: 15459494 Clinical Trial.
In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells.
Maddaloni M, Farra R, Dapas B, Felluga F, Benedetti F, Berti F, Drioli S, Vidali M, Cemazar M, Kamensek U, Brancolini C, Murano E, Maremonti F, Grassi M, Biasin A, Rizzolio F, Cavarzerani E, Scaggiante B, Bulla R, Balduit A, Ricci G, Zito G, Romano F, Bonin S, Azzalini E, Baj G, Tierno D, Grassi G. Maddaloni M, et al. Among authors: grassi m. Pharmaceutics. 2024 May 15;16(5):664. doi: 10.3390/pharmaceutics16050664. Pharmaceutics. 2024. PMID: 38794326 Free PMC article.
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort.
Vanni I, Pastorino L, Andreotti V, Comandini D, Fornarini G, Grassi M, Puccini A, Tanda ET, Pastorino A, Martelli V, Mastracci L, Grillo F, Cabiddu F, Guadagno A, Coco S, Allavena E, Barbero F, Bruno W, Dalmasso B, Bellomo SE, Marchiò C, Spagnolo F, Sciallero S, Berrino E, Ghiorzo P. Vanni I, et al. Among authors: grassi m. J Transl Med. 2024 May 15;22(1):462. doi: 10.1186/s12967-024-05227-2. J Transl Med. 2024. PMID: 38750555 Free PMC article.
1,128 results